






Epidemiological investigation reveals local transmission of SARS-CoV-2 lineage P.1 in 
Southern Brazil 
Investigação epidemiológica revela transmissão local da variante P.1 do SARS-CoV-2 no Sul 
do Brasil 
Una investigación epidemiológica revela la transmisión local de la variante P.1 del SARS-
CoV-2 en el sur de Brasil 
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Since its detection in December of 2020, the SARS-CoV2 lineage P.1, descendent of B.1.1.28 
lineage, has been identified in several places in Brazil and abroad. This Variant of Concern was 
considered highly prevalent in Northern Brazil and now is rapidly widening its geographical 
range. Here, we present epidemiological and genomic information of the first case of P1 lineage 
in Rio Grande do Sul state, in a patient without reported travel history and a tracked 
transmission chain. These findings occurred in a tourist destination representing an important 
hub receiving tourists from diverse places. 
Keywords: SARS-CoV-2. COVID-19. transmission. B.1.1.28. 
RESUMO 
Desde a sua detecção em dezembro de 2020, a linhagem P.1 do SARS-CoV2, descendente da 
linhagem B.1.1.28, foi identificada em diversos locais no Brasil e no mundo. Essa variante de 
preocupação era considerada altamente frequente no Norte do Brasil e agora está ampliando 
rapidamente sua distribuição geográfica. Aqui, apresentamos informações epidemiológicas e 
genômicas do primeiro caso da linhagem P.1 no Rio Grande do Sul em um paciente sem 
histórico de viagens relatado e com cadeia de transmissão identificada. Esses achados 
ocorreram em um destino turístico que representa um importante pólo de recepção de turistas 
de diversas localidades. 
Descritores: SARS-CoV-2. COVID-19. transmissão. B.1.1.28. 
 
RESUMEN 
Desde su detección en diciembre de 2020, del linaje P.1 del SARS-CoV2, derivada de la 
B.1.1.28, hay sido ampliamente identificada en Brasil y en todo el mundo. Esta variante 
preocupante es muy frecuente en el norte de Brasil y ahora está ampliando rápidamente su 
distribución geográfica. Aquí, presentamos información epidemiológica y genómica del primer 
caso de P.1 en Rio Grande do Sul en un paciente sin antecedentes de viaje y con una cadena de 
transmisión identificada. Estos datos se han obtenido en un destino turístico que representa un 
importante centro de acogida de turistas de diferentes lugares. 
Palabras clave: SARS-CoV-2. COVID-19. transmisión. B.1.1.28. 
 
Recently, a new variant first detected in Manaus/Amazonas in the North Region of 
Brazil has become a concern worldwide. The named P.1 lineage is descendent of B.1.1.28 
lineage and carries a set of mutations with important biological significance, mainly at region 
encoding spike protein (E484K, K417T and N501Y) (N.R. Faria, et al., unpub. data, 
https://virological.org/t/genomic-characterisation-of-an-emergent-sars-cov-2-lineage-in-
manaus-preliminary-findings/586).  
The P.1 lineage emerged with high frequency in a short period of time, spreading fast 
in North of Brazil, and in the recent weeks in other cities from Southeastern Brazil (F. Naveca 
et al., unpub. data, https://virological.org/t/sars-cov-2-reinfection-by-the-new-variant-of-




CoV-2 P.1 lineage in Rio Grande do Sul, the southernmost state in Brazil. The case occurred 
in Gramado city, a mountain town with German colonization that receives 6.5 million tourists 
every year. Gramado belongs to the 5th Regional Health Coordination (an administrative 
division) that comprises 49 municipalities with a 1,240,319 estimated population, also known 
as Caxias do Sul Region (https://cidades.ibge.gov.br/brasil/panorama). 
An 88-years-old male patient (A) presented acute respiratory symptoms on Jan 29th, 
2021 and was hospitalized on Feb 3rd after medical examination. At the same day, the patient 
was admitted at the intensive care unit with fever of 39ºC, no leg movements, chest pain, 
besides flu-like symptoms/Acute Respiratory Syndrome. Respiratory secretion was collected 
on Feb 1st and RT-qPCR for SARS-CoV-2 detection was performed at Central Laboratory of 
Public Health from Rio Grande do Sul (LACEN-RS). The RNA was extracted from respiratory 
clinical sample through MagMAX Viral/Pathogen II Isolation kit on KingFischer Flex 
extractor (Thermo Fisher Scientific, Waltham, USA). The multiple detection of 3 target genes 
(E gene, RdRP gene and N gene) from pathogen was performed on Applied Biosystems 7500 
Real-Time PCR System (Thermo Fisher Scientific, Waltham, USA), using Allplex SARS-
CoV-2 Assay  (Seegene Inc, Seoul, Republic of Korea). The SARS-CoV-2 RT-qPCR was 
positive (Ct 22) and the result released on Feb 2nd, the patient died on Feb 10th, nine days after 
hospitalization. 
As part of SARS-CoV-2 genomic surveillance in Rio Grande do Sul State, the collected 
sample, along with samples from different cities, were sequenced aiming to obtain the current 
scenario of SARS-CoV-2 genomic diversity in this region. Whole genome library preparation 
of SARS-CoV-2 was performed using QIAseq SARS-CoV-2 Primer Panel paired with QIAseq 
FX DNA Library UDI Kit, according to the manufacturer instructions. The sequencing was 
performed on an Illumina MiSeq machine using MiSeq Reagent Kit v3 (600-cycle). Raw 
FASTQ files from genome sequencing were firstly trimmed to remove adapter sequences and 
low-quality reads using trimmomatic1 the read data quality assessed in fastQC 
(www.bioinformatics.babraham.ac.uk/projects/fastqc/) and then mapped against the reference 
genome Wuhan-Hu-1 (GenBank Accession MN908947.3) using the BWA-MEM algorithm2 
(Mean coverage: 2.158,216). Consensus fasta was obtained with SAMtools3. 
The sequenced genome was assigned to P.1 lineage on Pangolin (github.com/cov-
lineages/pangolin). Thus, we aligned the consensus fasta with other 156 P.1 genomes from 
worldwide available on GISAID4 as of Feb 16, 2021 with MAFFT5 under default parameters. 
The aligned multi-fasta was used to construct a maximum-likelihood tree in IQ-Tree v.2.1.26 




Wuhan-Hu-1 reference genome. The maximum-likelihood phylogenetic analyses revealed that 
the sequence from Gramado, Rio Grande do Sul, is branched in a monophyletic clade that 
comprises 25 genomes including sequences from Amazonas, Rondônia, Roraima and São 
Paulo state, along with sequences found in Japan and Colombia (Figure 1).  
 
Figure 1 - Maximum-likelihood tree from the first SARS-CoV P.1 genome identified in Rio Grande do Sul 
(Brazil) contextualized on 156 P.1 genomes from worldwide. The aLRT support values are shown in key nodes. 
Tip colors indicate the origin of samples. Triangles are indicating the samples from three patients from Amazonas 
(Brazil), transferred to Rio Grande do Sul to receive hospital care. The first SARS-CoV P.1 genome identified in 
Rio Grande do Sul it is highlighted in purple. 
 
The patient (A) had no travel history, and the epidemiological investigation revealed a 
transmission chain as follows (linkages were omitted for privacy-preserving): he lived in a rural 
area, nearby the city, under self-isolation, and had daily contact with a person (B). This person 
had previous contact in a diner with an individual (C) on Jan 23rd, a tourism worker who used 
to have close contact with tourists and was positive to COVID-19 with onset symptoms on Jan 
21st. (B) presented her first symptoms on Jan 26th and had a positive RT-qPCR test for SARS-
CoV-2 on Jan 31st, presenting mild disease; (C) to date remains hospitalized with severe disease 
symptoms. Colleagues who shared the same workplace to (C) were also diagnosed with 




period the hospitalizations have risen in Gramado and more than 3-fold in the neighboring city, 
Canela, also a touristic city. 
Our findings indicate a local transmission of P.1 lineage occurring in Gramado, and 
revealed a worrying emergence of severe COVID-19 cases in this region. It calls for future use 
of genomic surveillance as a regular and permanent tool to identify the underlying events as in 
the present case, where, due to genomic surveillance, it was possible to detect an unsuspected 
variant of concern P.1 on a case of COVID-19 death in a patient practicing self-isolation, living 
in a remote area.  
Our analysis highlights monitoring protocols for new variants must consider key social 
mobilization sites in the state. From all cities of Rio Grande do Sul state, Gramado and Canela 
are by far the most important from the point of view of social mobility, as they receive tourists 
from Brazil and abroad. The Capital and the border/port regions must also be constantly 
monitored in order to guarantee success in monitoring new circulating strains. The joint 
observation of epidemiological and laboratory surveillance findings can assist the community 
in COVID-19 control measures. 
 
Data availability: Whole genome sequence from SARS-CoV-2 genome sequenced in this 
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